Status:
COMPLETED
Effectiveness of the Solio Alfa Care Plus Device in Treating Low Back Pain
Lead Sponsor:
Sheba Medical Center
Conditions:
Low Back Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Objectives: This double-blind, randomized, prospective, single-centre study evaluated the effectiveness of radiofrequency therapy by the SOLIO Alfa Cure Plus in the treatment of a non-specific low bac...
Detailed Description
Studies have shown that some generally recommended first-line medications for low back pain (LPB) are only slightly more effective than placebo controls in double-blind randomized trials \[10\]. For i...
Eligibility Criteria
Inclusion
- Patients with LBP lasting 6 weeks and less than 6 months (NRS) of 4 or higher), between 18 to 70 years old that possessed assistance of family members
Exclusion
- patients with fibromyalgia, pregnancy, pacemaker implant, hyper coagulation, cognitive impairment, psychosis diagnosis, addiction, opiate usage, malignant cancer, and BMI \> 35 or 18.5
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT06053034
Start Date
March 1 2023
End Date
September 1 2023
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel